Coursera Drugs and the Brain |
||
|
Name |
DOWNLOAD Copy Link | |
|
Total Size |
1.8 GB |
|
|
Total Files |
354 |
|
|
Hash |
802F6FFF5C5F4BF01F23AEFAD0E7AAEB8D2FF545 |
|
/.../01 - 3. What is a Drug (13-44)/ |
|
|
|
47.4 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
15.3 KB |
|
|
9.3 KB |
|
/.../01 - 1 Classifying Psychiatric Diseases (18-04)/ |
|
|
|
33.5 MB |
|
|
376.8 KB |
|
|
345.6 KB |
|
|
20.7 KB |
|
|
12.8 KB |
|
/.../04 - 4 Therapeutic Approaches Protection By Small Molecules (17-23)/ |
|
|
12 - 4 - 4 Therapeutic Approaches Protection By Small Molecules (1723).mp4 |
28.2 MB |
|
|
6.7 MB |
|
|
6.1 MB |
|
12 - 4 - 4 Therapeutic Approaches Protection By Small Molecules (1723).srt |
21.4 KB |
|
12 - 4 - 4 Therapeutic Approaches Protection By Small Molecules (1723).txt |
13.1 KB |
|
/.../02 - 2 Pathophysiology Non-human Models (16-26)/ |
|
|
|
26.3 MB |
|
|
6.7 MB |
|
|
6.1 MB |
|
|
19.0 KB |
|
|
11.7 KB |
|
/.../02 - 2 Pathophysiology. A Century of Frustration (13-48)/ |
|
|
18 - 2 - 2 Pathophysiology. A Century of Frustration (1348).mp4 |
24.4 MB |
|
|
6.2 MB |
|
|
5.6 MB |
|
18 - 2 - 2 Pathophysiology. A Century of Frustration (1348).srt |
15.9 KB |
|
18 - 2 - 2 Pathophysiology. A Century of Frustration (1348).txt |
9.9 KB |
|
/.../01 - 1 Clinical Description and Genetics (13-20)/ |
|
|
|
23.5 MB |
|
|
9.7 MB |
|
|
7.8 MB |
|
|
15.7 KB |
|
|
9.6 KB |
|
/.../01 - 1 Overview, Summary, Prospects (13-51)/ |
|
|
|
22.6 MB |
|
|
2.7 MB |
|
|
2.2 MB |
|
|
16.8 KB |
|
|
10.2 KB |
|
/.../03 - 3 Circuit and Cellular Level Upregulation via Inside-Out Mechanisms (16-34)/ |
|
|
9 - 3 - 3 Circuit and Cellular Level Upregulation via Inside-Out Mechanisms (1634).mp4 |
21.4 MB |
|
|
9.1 MB |
|
|
2.7 MB |
|
9 - 3 - 3 Circuit and Cellular Level Upregulation via Inside-Out Mechanisms (1634).srt |
19.8 KB |
|
9 - 3 - 3 Circuit and Cellular Level Upregulation via Inside-Out Mechanisms (1634).txt |
11.9 KB |
|
/.../01 - 1 Clinical Picture Genetics (12-07)/ |
|
|
|
20.2 MB |
|
|
6.7 MB |
|
|
6.1 MB |
|
|
14.5 KB |
|
|
8.8 KB |
|
/.../04 - 4 Additional Antidepressant Mechanisms (12-06)/ |
|
|
|
20.0 MB |
|
|
9.7 MB |
|
|
7.8 MB |
|
|
13.6 KB |
|
|
8.6 KB |
|
/.../01 - 1 Clinical Description Genetics (11-24)/ |
|
|
|
19.9 MB |
|
|
6.2 MB |
|
|
5.6 MB |
|
|
12.4 KB |
|
|
7.6 KB |
|
/.../02 - 2 Pathophysiology (16-12)/ |
|
|
|
19.9 MB |
|
|
3.2 MB |
|
|
1.5 MB |
|
|
18.5 KB |
|
|
11.5 KB |
|
/.../05 - 7. Introduction to Mammalian Brains (9-59)/ |
|
|
|
19.3 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
12.1 KB |
|
|
7.3 KB |
|
/.../01 - 1 Drugs Bind to Neurotransmitter Transporters (15-41)/ |
|
|
7 - 1 - 1 Drugs Bind to Neurotransmitter Transporters (1541).mp4 |
19.0 MB |
|
|
7.8 MB |
|
|
1.9 MB |
|
7 - 1 - 1 Drugs Bind to Neurotransmitter Transporters (1541).srt |
18.1 KB |
|
7 - 1 - 1 Drugs Bind to Neurotransmitter Transporters (1541).txt |
11.1 KB |
|
/.../04 - 4 Inhibitory Ligand-gated channels (9-51)/ |
|
|
|
18.4 MB |
|
|
13.3 MB |
|
|
7.0 MB |
|
|
12.8 KB |
|
|
7.9 KB |
|
/.../03 - 3 Nicotinic Acetylcholine Receptors Desensitization (5-14)/ |
|
|
|
18.4 MB |
|
|
7.0 MB |
|
4 - 3 - 3 Nicotinic Acetylcholine Receptors Desensitization (514).mp4 |
5.9 MB |
|
4 - 3 - 3 Nicotinic Acetylcholine Receptors Desensitization (514).srt |
6.6 KB |
|
4 - 3 - 3 Nicotinic Acetylcholine Receptors Desensitization (514).txt |
4.1 KB |
|
/.../01 - 1 The Synapse as a Drug-Sensitive Biophysical Machine (8-08)/ |
|
|
|
18.4 MB |
|
4 - 1 - 1 The Synapse as a Drug-Sensitive Biophysical Machine (808).mp4 |
12.1 MB |
|
|
7.0 MB |
|
4 - 1 - 1 The Synapse as a Drug-Sensitive Biophysical Machine (808).srt |
9.7 KB |
|
4 - 1 - 1 The Synapse as a Drug-Sensitive Biophysical Machine (808).txt |
6.0 KB |
|
/.../02 - 2 Nicotinic Acetylcholine Receptors Activation (10-41)/ |
|
|
|
18.4 MB |
|
4 - 2 - 2 Nicotinic Acetylcholine Receptors Activation (1041).mp4 |
13.9 MB |
|
|
7.0 MB |
|
4 - 2 - 2 Nicotinic Acetylcholine Receptors Activation (1041).srt |
13.1 KB |
|
4 - 2 - 2 Nicotinic Acetylcholine Receptors Activation (1041).txt |
8.1 KB |
|
/.../05 - 5 Glutamate-gated receptor channels (11-26)/ |
|
|
|
18.4 MB |
|
|
14.6 MB |
|
|
7.0 MB |
|
|
14.3 KB |
|
|
8.8 KB |
|
/.../03 - 3 Metabolism and Breakdown of Drugs (10-30)/ |
|
|
|
18.2 MB |
|
|
5.2 MB |
|
|
2.4 MB |
|
|
12.0 KB |
|
|
7.4 KB |
|
/.../03 - 3 System level effects (14-18)/ |
|
|
|
18.0 MB |
|
|
2.1 MB |
|
|
1.4 MB |
|
|
16.5 KB |
|
|
10.3 KB |
|
/.../05 - 5 Subcellular Pharmacokinetics (9-35)/ |
|
|
|
17.9 MB |
|
|
5.2 MB |
|
|
2.4 MB |
|
|
11.0 KB |
|
|
6.9 KB |
|
/.../03 - 3 Therapeutic Approaches Symptom Relief (10-34)/ |
|
|
|
17.5 MB |
|
|
6.7 MB |
|
|
6.1 MB |
|
|
12.5 KB |
|
|
7.8 KB |
|
/.../03 - 3 The Amygdala and Fear in Animals (11-50)/ |
|
|
|
17.2 MB |
|
|
5.3 MB |
|
|
5.3 MB |
|
|
12.7 KB |
|
|
7.6 KB |
|
/.../03 - 3 Mechanisms of Antidepressant Action (10-08)/ |
|
|
|
17.1 MB |
|
|
9.7 MB |
|
|
7.8 MB |
|
|
11.0 KB |
|
|
6.8 KB |
|
/.../01 - 1 Principles and Receptors (13-50)/ |
|
|
|
17.1 MB |
|
|
3.2 MB |
|
|
2.1 MB |
|
|
15.9 KB |
|
|
9.7 KB |
|
/.../05 - 5 Drugs for smoking cessation Harm Reduction (14-10)/ |
|
|
9 - 5 - 5 Drugs for smoking cessation Harm Reduction (1410).mp4 |
17.1 MB |
|
|
9.1 MB |
|
|
2.7 MB |
|
9 - 5 - 5 Drugs for smoking cessation Harm Reduction (1410).srt |
15.5 KB |
|
9 - 5 - 5 Drugs for smoking cessation Harm Reduction (1410).txt |
9.6 KB |
|
/.../01 - 1 Components of addiction. Animal models (15-13)/ |
|
|
|
16.8 MB |
|
|
9.1 MB |
|
|
2.7 MB |
|
|
17.4 KB |
|
|
10.8 KB |
|
/.../05 - 5 Outside-in Mechanisms for Long-term Actions on G Protein Pathways (12-51)/ |
|
|
6 - 5 - 5 Outside-in Mechanisms for Long-term Actions on G Protein Pathways (1251).mp4 |
16.7 MB |
|
|
3.2 MB |
|
|
2.1 MB |
|
6 - 5 - 5 Outside-in Mechanisms for Long-term Actions on G Protein Pathways (1251).srt |
14.0 KB |
|
6 - 5 - 5 Outside-in Mechanisms for Long-term Actions on G Protein Pathways (1251).txt |
8.6 KB |
|
/.../04 - 6. More about receptors as proteins (13-22)/ |
|
|
|
16.6 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
16.5 KB |
|
|
10.1 KB |
|
/.../04 - 4 Recent Genetic Data (13-05)/ |
|
|
|
16.5 MB |
|
|
9.1 MB |
|
|
2.7 MB |
|
|
13.9 KB |
|
|
8.4 KB |
|
/.../01 - 1 Clinical Description, Genetics (9-40)/ |
|
|
|
16.2 MB |
|
|
723.0 KB |
|
|
714.3 KB |
|
|
11.4 KB |
|
|
6.9 KB |
|
/.../06 - 8. Techniques for Studying the Brain (10-56)/ |
|
|
|
16.1 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
12.2 KB |
|
|
7.3 KB |
|
/.../07 - 9. Botulinum toxin (9-41)/ |
|
|
|
15.9 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
11.2 KB |
|
|
6.9 KB |
|
/.../03 - 3 Outside-In Mechanisms (12-01)/ |
|
|
|
15.5 MB |
|
|
2.5 MB |
|
|
1.5 MB |
|
|
14.2 KB |
|
|
8.8 KB |
|
/.../03 - 3 Nongenetic contributions, Biomarkers, Animal Models (10-06)/ |
|
|
18 - 3 - 3 Nongenetic contributions, Biomarkers, Animal Models (1006).mp4 |
15.4 MB |
|
|
6.2 MB |
|
|
5.6 MB |
|
18 - 3 - 3 Nongenetic contributions, Biomarkers, Animal Models (1006).srt |
11.9 KB |
|
18 - 3 - 3 Nongenetic contributions, Biomarkers, Animal Models (1006).txt |
7.3 KB |
|
/.../05 - 5 Therapeutic Approaches Protection By Proteins or Gene Therapy (9-10)/ |
|
|
12 - 5 - 5 Therapeutic Approaches Protection By Proteins or Gene Therapy (910).mp4 |
15.2 MB |
|
|
6.7 MB |
|
|
6.1 MB |
|
12 - 5 - 5 Therapeutic Approaches Protection By Proteins or Gene Therapy (910).srt |
10.6 KB |
|
12 - 5 - 5 Therapeutic Approaches Protection By Proteins or Gene Therapy (910).txt |
6.6 KB |
|
/.../02 - 2 Pathophysiology, Animal Models, Biomarkers (8-50)/ |
|
|
16 - 2 - 2 Pathophysiology, Animal Models, Biomarkers (850).mp4 |
14.9 MB |
|
|
9.7 MB |
|
|
7.8 MB |
|
16 - 2 - 2 Pathophysiology, Animal Models, Biomarkers (850).srt |
10.1 KB |
|
16 - 2 - 2 Pathophysiology, Animal Models, Biomarkers (850).txt |
6.3 KB |
|
/.../02 - 4. Drug Entry Into the Nervous System (12-52)/ |
|
|
|
14.8 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
15.6 KB |
|
|
9.6 KB |
|
/.../02 - 2 Circuit and cellular level. Outside-In Mechanisms (11-23)/ |
|
|
9 - 2 - 2 Circuit and cellular level. Outside-In Mechanisms (1123).mp4 |
14.4 MB |
|
|
9.1 MB |
|
|
2.7 MB |
|
9 - 2 - 2 Circuit and cellular level. Outside-In Mechanisms (1123).srt |
13.5 KB |
|
9 - 2 - 2 Circuit and cellular level. Outside-In Mechanisms (1123).txt |
8.2 KB |
|
/.../01 - 1. Organization and Overview, weeks 1 - 3 (11-39)/ |
|
|
1 - 1 - 1. Organization and Overview, weeks 1 - 3 (1139).mp4 |
14.4 MB |
|
|
5.2 MB |
|
|
1.9 MB |
|
1 - 1 - 1. Organization and Overview, weeks 1 - 3 (1139).srt |
13.3 KB |
|
1 - 1 - 1. Organization and Overview, weeks 1 - 3 (1139).txt |
8.2 KB |
|
/.../04 - 4 Drugs for Schizophrenia (8-30)/ |
|
|
|
14.4 MB |
|
|
6.2 MB |
|
|
5.6 MB |
|
|
9.4 KB |
|
|
5.8 KB |
|
/.../01 - 1 Pharmacokinetic Principles (8-45)/ |
|
|
|
14.3 MB |
|
|
5.2 MB |
|
|
2.4 MB |
|
|
10.4 KB |
|
|
6.5 KB |
|
/.../02 - 2 Neurotransmitter Transporters as Molecules (11-04)/ |
|
|
7 - 2 - 2 Neurotransmitter Transporters as Molecules (1104).mp4 |
14.2 MB |
|
|
7.8 MB |
|
|
1.9 MB |
|
7 - 2 - 2 Neurotransmitter Transporters as Molecules (1104).srt |
12.5 KB |
|
7 - 2 - 2 Neurotransmitter Transporters as Molecules (1104).txt |
7.7 KB |
|
/.../04 - 4 The Ca-mobilizing G protein (Gq) pathway Modifying G protein Pathways (11-13)/ |
|
|
6 - 4 - 4 The Ca-mobilizing G protein (Gq) pathway Modifying G protein Pathways (1113).mp4 |
14.2 MB |
|
|
3.2 MB |
|
|
2.1 MB |
|
6 - 4 - 4 The Ca-mobilizing G protein (Gq) pathway Modifying G protein Pathways (1113).srt |
11.6 KB |
|
6 - 4 - 4 The Ca-mobilizing G protein (Gq) pathway Modifying G protein Pathways (1113).txt |
6.9 KB |
|
/.../03 - 3 The Stimulatory G Protein (Gs) Pathway (11-48)/ |
|
|
|
14.0 MB |
|
|
3.2 MB |
|
|
2.1 MB |
|
|
13.1 KB |
|
|
8.1 KB |
|
/.../02 - 2 Voltage-gated channel blockers (11-27)/ |
|
|
|
13.8 MB |
|
|
6.3 MB |
|
|
1.5 MB |
|
|
14.5 KB |
|
|
8.9 KB |
|
/.../01 - 1 Components of Opiate Addiction (10-26)/ |
|
|
|
13.7 MB |
|
|
2.5 MB |
|
|
1.5 MB |
|
|
12.1 KB |
|
|
7.3 KB |
|
/.../01 - 1 Clinical Description Genetics (10-48)/ |
|
|
|
13.6 MB |
|
|
3.2 MB |
|
|
1.5 MB |
|
|
12.3 KB |
|
|
7.6 KB |
|
/.../02 - 2 The Amygdala and Fear in Humans (9-22)/ |
|
|
|
13.5 MB |
|
|
5.3 MB |
|
|
5.3 MB |
|
|
10.4 KB |
|
|
6.4 KB |
|
/.../02 - 2 Circuits and Animal Models (10-19)/ |
|
|
|
13.4 MB |
|
|
2.5 MB |
|
|
1.5 MB |
|
|
11.7 KB |
|
|
7.4 KB |
|
/.../02 - 2 LogP and LogD (8-19)/ |
|
|
|
13.3 MB |
|
|
5.2 MB |
|
|
2.4 MB |
|
|
9.7 KB |
|
|
6.1 KB |
|
/.../01 - 1 Qualitative Approaches (9-55)/ |
|
|
|
13.2 MB |
|
|
1.2 MB |
|
|
969.7 KB |
|
|
12.5 KB |
|
|
7.7 KB |
|
/.../04 - 4 Drugs for Anxiety (8-13)/ |
|
|
|
13.2 MB |
|
|
5.3 MB |
|
|
5.3 MB |
|
|
10.0 KB |
|
|
6.3 KB |
|
/.../01 - 1 Overview (10-56)/ |
|
|
|
13.2 MB |
|
|
2.1 MB |
|
|
1.4 MB |
|
|
11.7 KB |
|
|
7.2 KB |
|
/.../03 - 5. Introduction to Drug Receptors (11-55)/ |
|
|
|
13.1 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
13.5 KB |
|
|
8.2 KB |
|
/.../03 - 3 Drugs and Other Therapies (8-18)/ |
|
|
|
13.1 MB |
|
|
723.0 KB |
|
|
714.3 KB |
|
|
9.6 KB |
|
|
5.8 KB |
|
/.../09 - 11. Electrical Aspects of Ion Channels (8-48)/ |
|
|
|
12.7 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
10.2 KB |
|
|
6.3 KB |
|
/.../01 - 1 Definitions (7-19)/ |
|
|
|
12.5 MB |
|
|
5.3 MB |
|
|
5.3 MB |
|
|
7.3 KB |
|
|
4.4 KB |
|
/.../02 - 2. Organization and Overview, weeks 4- 7 (9-52)/ |
|
|
|
12.4 MB |
|
|
5.2 MB |
|
|
1.9 MB |
|
|
12.0 KB |
|
|
7.4 KB |
|
/.../02 - 2 Quantitative Approaches, Agonist Only (10-08)/ |
|
|
|
11.9 MB |
|
|
1.2 MB |
|
|
969.7 KB |
|
|
11.9 KB |
|
|
7.2 KB |
|
/.../04 - 4 Pharmacokinetic Simulations (6-53)/ |
|
|
|
11.8 MB |
|
|
5.2 MB |
|
|
2.4 MB |
|
|
8.1 KB |
|
|
4.9 KB |
|
/.../08 - 10. Origin of the Resting Potential (10-04)/ |
|
|
|
11.5 MB |
|
|
11.3 MB |
|
|
3.9 MB |
|
|
12.8 KB |
|
|
7.7 KB |
|
/.../02 - 2 Inhibitory G Proteins and their Effectors (7-10)/ |
|
|
6 - 2 - 2 Inhibitory G Proteins and their Effectors (710).mp4 |
11.4 MB |
|
|
3.2 MB |
|
|
2.1 MB |
|
6 - 2 - 2 Inhibitory G Proteins and their Effectors (710).srt |
8.6 KB |
|
6 - 2 - 2 Inhibitory G Proteins and their Effectors (710).txt |
5.3 KB |
|
/.../02 - 2 Heterozygote Advantage (5-07)/ |
|
|
|
10.6 MB |
|
|
723.0 KB |
|
|
714.3 KB |
|
|
6.1 KB |
|
|
3.7 KB |
|
/.../02 - 2 Targets (8-35)/ |
|
|
|
10.4 MB |
|
|
2.1 MB |
|
|
1.4 MB |
|
|
9.7 KB |
|
|
6.1 KB |
|
/.../03 - 3 Biomarkers Therapeutic Approaches (8-58)/ |
|
|
|
10.4 MB |
|
|
3.2 MB |
|
|
1.5 MB |
|
|
10.0 KB |
|
|
6.3 KB |
|
/.../03 - 3 Agonists plus Antagonists (7-55)/ |
|
|
|
9.8 MB |
|
|
1.2 MB |
|
|
969.7 KB |
|
|
8.8 KB |
|
|
5.4 KB |
|
/.../01 - 1 Pore Blockers at ligand-gated channels (6-50)/ |
|
|
|
8.5 MB |
|
|
6.3 MB |
|
|
1.5 MB |
|
|
7.9 KB |
|
|
5.0 KB |
|
/.../04 - 4 Drugs for Harm Reduction in Opiate Addiction (5-23)/ |
|
|
10 - 4 - 4 Drugs for Harm Reduction in Opiate Addiction (523).mp4 |
6.7 MB |
|
|
2.5 MB |
|
|
1.5 MB |
|
10 - 4 - 4 Drugs for Harm Reduction in Opiate Addiction (523).srt |
6.5 KB |
|
10 - 4 - 4 Drugs for Harm Reduction in Opiate Addiction (523).txt |
4.0 KB |
|
/ |
|
|
|
198.0 KB |
|
|
32.5 KB |
|
|
15.2 KB |
|
|
2.2 KB |
|
Total files 354 |
|
Copyright © 2024 FileMood.com